LIPO (Lipella Pharmaceuticals) Kacepetan wutah bathi saben saham ing taun lumaku
Stable raw material supply chains minimize bottleneck risks for Lipella Pharmaceuticals (LIPO). Patent protection within the urological treatment niche guarantees the company sustainable pricing power. Growth potential is based on the transition from costly research to mass production. The annual EPS difference in percentage terms demonstrates the real efficiency of the business, where the 0.00 metric determines this level.
Rincian analitis lan laporan data perusahaan Lipella Pharmaceuticals (LIPO)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Koefisien Total Utang marang Modal Lipella Pharmaceuticals|LIPO - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Lipella Pharmaceuticals, Inc.|LIPO - Gunggung utang perusahaan|Utang-utang marang nilai buku Lipella Pharmaceuticals, Inc.|LIPO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lipella Pharmaceuticals|Likuiditas cepet lipella.com
- indikator pendapatan resik lan kelipatan nilai:
LIPO - Bathi resik|Proyeksi bathi mangsa ngarep Lipella Pharmaceuticals|LIPO - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi lipella.com|LIPO - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Lipella Pharmaceuticals|LIPO - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Lipella Pharmaceuticals|LIPO - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan lipella.com|LIPO - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Lipella Pharmaceuticals
- data pendapatan lan penerimaan dodolan:
Pambiji fundamental:LIPO Lipella Pharma
This indicator assesses revenue resilience amid currency volatility, determining real business efficiency through earnings per share dynamics. The formula captures the percentage deviation of current EPS from last year's figures, revealing the growth or degradation rates of capitalization. By analyzing the shift in earnings per share compared to last year, an investor can evaluate the commercialization potential of Lipella Pharmaceuticals (LIPO) targeted therapy within the urological segment.
Pesaing utama
Kacepetan wutah bathi saben saham ing taun lumaku Haleon Corp (HLN)|KVUE (Kenvue Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku veronapharma.com VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Dinamika bathi saben saham ing taun lumaku|ALVO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki liquidia.com LQDA|Galapagos (GLPG) - Wutah bathi saben saham ing taun lumaku|ANIP - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku MannKind Corporation|AMPH: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Pacira BioSciences (PCRX)|SPRY: Dinamika bathi saben saham ing taun lumaku|Theravance Biopharma, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku AQST (Aquestive Therapeutics, Inc.)|SCPH - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki tectonictx.com TECX|TNXP: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki SXTC|Wutah bathi resik saben saham ing taun iki EPRX|BioHarvest (BHST) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku EXOZ|Wutah bathi ing taun lumaku Oramed (ORMP)|Entera Bio Ltd. - Wutah bathi resik saben saham ing taun iki|ipatherapeutics.com (HYFT) - Kacepetan wutah bathi saben saham ing taun lumaku|ABVC - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku CPIX|QNTM: Wutah bathi ing taun lumaku|FGEN - Prakiraan wutah bathi resik saben saham ing taun iki|TELO (Telomir Pharmaceuticals Corp) - Wutah bathi ing taun lumaku|RANI (Rani Therapeutics) - Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Synergy CHC Corp. (SNYR)|RLYB (Rallybio) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku lexariabioscience.com LEXX|Wutah bathi ing taun lumaku Pulmatrix Corporation PULM|PTHL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Aptorum Group Ltd APM|LYRA (Lyra Therapeutics) - Wutah bathi resik saben saham ing taun iki|IBO - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku TNF Pharmaceuticals, Inc.|Wutah bathi resik saben saham ing taun iki cbdMD, Inc. (YCBD)|Wutah bathi saben saham ing taun lumaku PainReform Limited (PRFX)|Wutah bathi resik saben saham ing taun iki Altamira Therapeutics Ltd CYTO|Wutah bathi saben saham ing taun lumaku OptiNose OPTN|Pieris Pharmaceuticals Inc - Wutah bathi saben saham ing taun lumaku|Procaps Group Corp - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Wutah bathi saben saham ing taun lumaku|ACELYRIN (SLRN) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku TFF Pharmaceuticals
